Faculty of Medicine

Infection, Immunology and Inflammation

Infection, Immunology and Inflammation research shares the common goal of integrating discovery science with clinical medicine to treat or prevent diseases of global importance, across microbiology, virology, autoimmunity and inflammation.

Our groups form one of the largest centres for infection, immunology and inflammation research in Europe. All our Centres collaborate extensively with Imperial College-associated hospitals, industry and Public Health England with complementary expertise to achieve this goal.

Our immunology and inflammation research programmes include the study of in vivo experimental model systems, renal pathology, the immunology of autoimmunity and complement genetics.

We founded the Centre for Complement and Inflammation Research to provide comprehensive ‘complotyping’ of patients from the UK and beyond. The Centre interfaces with the Imperial AHSC Lupus Centre to drive translational aspects of immunology and inflammation programmes. The Robert Hesketh Hepatology Clinical Research Facility has a DNA and tissue bank, linked with clinical data from several thousand patients in the HEP-Base database.

Our centres:

Medical Research Council (MRC) Centre for Molecular Bacteriology and Infection

MRC Centre for Molecular Bacteriology and Infection

MRC Centre for Molecular Bacteriology and Infection

The MRC Centre for Molecular Bacteriology and Infection uses multidisciplinary approaches and advanced techniques with the aim of developing new antibiotics, combating antibiotic resistance and developing effective vaccines.

UK Clinical Research Collaboration (UK CRC) Centre for Infection Prevention and Management

UK CRC Centre for Infection Prevention and Management is tackling the issue of healthcare acquired infection via a consortium approach that includes organisational research, social marketing, epidemiology, laboratory-based programmes and education.

Imperial Wellcome Trust Centre for Global Health Research

Imperial Wellcome Trust Centre for Global Health Research aims to translate advances in research into the treatment of major diseases such as tuberculosis, malaria and HIV, as well as other, non-communicable, diseases. The Centre provides a base at Imperial to support the careers and research of fellows at all levels of training who wish to carry out work in the field of global health research. We also host the International AIDS Vaccine Initiative (IAVI) Human Immunology Laboratory which supports HIV vaccine development and trials.

National Centre for Human Retrovirology

Under the auspices of the Imperial Academic Health Sciences Centre (AHSC), we also host the National Centre for Human Retrovirology which coordinates research and provides National services for patients with human T-cell leukaemia virus infection; the Jefferiss Trust HIV Clinical Trials Unit which undertakes early clinical trials on HIV drugs and vaccines; and the Imperial International HIV Trials unit, responsible for managing international phase III programmes (e.g. Microbicide Development Programme, DART, SPARTAC, UKHVC and the AfrEVacc and TaMoVac vaccine trials).

Centre for Complement and Inflammation Research

Our immunology and inflammation research programmes include the study of in vivo experimental model systems, renal pathology, the immunology of autoimmunity and complement genetics.

We founded the Centre for Complement and Inflammation Research to provide comprehensive ‘complotyping’ of patients from the UK and beyond. The Centre interfaces with the Imperial AHSC Lupus Centre to drive translational aspects of immunology and inflammation programmes. The Robert Hesketh Hepatology Clinical Research Facility has a DNA and tissue bank, linked with clinical data from several thousand patients in HEP-Base database.

Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook
 
 

Key individuals

 

View our Masters Degrees